Study Questions Value of Interim PET Imaging to Guide Frontline Hodgkin Treatment
HOUSTON — Interim PET-CT imaging (PET2) had almost no impact on clinical decision-making for Hodgkin lymphoma treated with brentuximab vedotin (Adcetris), according to a small clinical study reported here. One of 40 patients had a change in treatment based on PET2 results, regardless of whether the scans were positive or negative. Outcomes did not differ […]
CDC Offers Tentative Guidance for Severe Mpox Treatment
With no clinical trial data yet available for treating severe mpox, the CDC has published an interim report with guidance. There are many FDA-regulated drugs and biologics stockpiled for smallpox preparedness that can be used to treat severe mpox; however, there are many clinical considerations when using these to help manage strategic decision-making, the CDC […]
Doc Groups Unhappy With HHS Rule on No Surprises Act
Some medical groups are none too happy with the “surprise billing” interim final rule issued yesterday by the Biden administration. The rule — issued jointly by the departments of Health and Human Services, Labor, and Treasury — implements part of the No Surprises Act, passed by Congress in December 2020 as part of a larger […]